Matrix metalloproteases and TIMPs as prognostic biomarkers in breast cancer patients treated with radiotherapy: A pilot study-Reference-Cited by-同舟云学术

Matrix metalloproteases and TIMPs as prognostic biomarkers in breast cancer patients treated with radiotherapy: A pilot study

Published:2019-09-30 Issue:1 Volume:24 Page:139-148
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cellular Molecular Medi

Author:

Olivares‐Urbano María Auxiliadora¹,Griñán‐Lisón Carmen²³,Zurita Mercedes⁴,Moral Rosario⁴,Ríos‐Arrabal Sandra¹,Artacho‐Cordón Francisco¹⁵^ORCID,Arrebola Juan Pedro⁵⁶,González Amanda Rocío⁷,León Josefa⁵^ORCID,Antonio Marchal Juan²³⁵^ORCID,Núñez María Isabel¹²⁵^ORCID

Affiliation:

1. Department of Radiology and Physical Medicine School of Medicine University of Granada Granada Spain

2. Biopathology and Regenerative Medicine Institute (IBIMER) Centre for Biomedical Research University of Granada Granada Spain

3. Department of Human Anatomy and Embryology School of Medicine University of Granada Granada Spain

4. Department of Radiation Oncology Virgen de las Nieves University Hospital Granada Spain

5. Biosanitary Research Institute, ibs.Granada Granada Spain

6. Department of Preventive Medicine and Public Health School of Medicine University of Granada Granada Spain

7. Bio‐Health Research Foundation of Eastern Andalusia ‐ Alejandro Otero (FIBAO) Granada Spain

Funder

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.14671

Reference55 articles.

1. Global Cancer Observatory.https://www.uicc.org/new-global-cancer-data-globocan-2018

2. Triple-negative breast cancer: new perspectives for targeted therapies

3. American Cancer Society.https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/types-of-breast-cancer.html

4. Rare Breast Cancer Subtypes: Histological, Molecular, and Clinical Peculiarities

5. Tailoring radiotherapy according to cancer subtypes

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating network pharmacology, molecular docking and experimental verification to reveal the mechanism of artesunate in inhibiting choroidal melanoma;Frontiers in Pharmacology;2024-08-09

2. Time trajectories and within-subject correlations of matrix metalloproteinases 3, 8, 9, 10, 12, and 13 serum levels and their ability to predict mortality in polytraumatized patients: a pilot study;European Journal of Medical Research;2024-04-10

3. Serum levels of matrix metalloproteinases 1, 2, and 7, and their tissue inhibitors 1, 2, 3, and 4 in polytraumatized patients: Time trajectories, correlations, and their ability to predict mortality;PLOS ONE;2024-03-08

4. Matrix Metalloproteinases and Their Inhibitors as Potential Prognostic Biomarkers in Head and Neck Cancer after Radiotherapy;International Journal of Molecular Sciences;2023-12-30

5. Serum Angiopoietin-2 level increase differs between polytraumatized patients with and without central nervous system injuries;Scientific Reports;2023-11-07